Expanding Inclusion for Long-Acting HIV Treatment Trials Workshop 11/10/2022

E-mail Print
Expanding Inclusion for Long-Acting HIV Treatment Trials Workshop was held on 11/10/2022 in Washington D.C.

Materials

pdfAgenda

pdfParticipant List

pdfExecutive Summary

 

Session I: Opening & Introductions

Session II: Lessons Learned & Opportunities

pdfLessons From HCV
Greg Dore, Kirby Institute

pdfView from the Trenches: West Virginia
Sally Hodder, Univeristy of West Virginia

pdfLessons from Other Fields: Psychiatry
Jonathan Liu, The George Washington University

Session III: Ensuring Access to Long-Acting ARVs -- Pre-Approval Setting

pdfLabel, Indications, and Expansion of Indications
Timothy Jancel, FDA CDER DAV

Session IV: Ensuring Access to Long-Acting ARVS -- Post-Approval Setting

pdfACTG 5359
Jose Castillo-Mancilla, University of Colorado Aschutz School of Medicine

pdfWard 86 Pilot Study
Monica Gandhi, Ward 86, UCSFn